@Ok_West_5560 1 day ago
IBRX founder speaking at Cancer 2035 summit with NIH leaders
IBRX founder speaking at Cancer 2035 summit with NIH leaders
ImmunityBio (IBRX) founder Dr. Patrick Soon-Shiong is speaking at the Cancer 2035 summit in D.C. starting today. He is listed alongside former NIH directors and executives from companies like Merck and Novocure. The event is co-hosted by the Milken Institute and focuses on strategies to reduce cancer mortality rates through immunotherapy and technology.
finance.yahoo.com
| ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken Institute and Richard Nixon Foundation "Cancer 2035: A Roadmap for the Future" Summit
@Simonwhite 1 day ago
seeing immunitybio listed alongside giants like merck is a big deal for them. following this summit closely to see if any new partnerships come out of it.
